ReCoUPS: Post-Concussion Patient Reports

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Completed
CT.gov ID
NCT04499937
Collaborator
University of Pennsylvania (Other)
30
2
4
23.2
15
0.6

Study Details

Study Description

Brief Summary

Physical and cognitive rest are recommended as treatment for concussion, but debate persists about the utility of this recommendation for patients recovering from concussion. In addition, patient adherence to physical and cognitive rest recommendations after concussion remains unknown. This study will measure and compare symptom and activity reports in the days and weeks after a concussion among patients randomly assigned to different incentive-based arms.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Streak incentive
  • Behavioral: Loss-based incentive
  • Behavioral: Flat-fee control status quo condition
  • Behavioral: Flat-Fitbit control status quo condition
N/A

Detailed Description

Although physical and cognitive rest are recommended as the hallmark treatment for concussion, debate persists about the utility of this recommendation for patients recovering from a concussion. In addition, patient adherence to physical and cognitive rest recommendations after concussion remains unknown. Objective and timely measures of physical and cognitive activity will aid in defining the relationship between physical and cognitive rest and clinical outcomes, such as symptom status, in the days and weeks after a concussion. Random assignment to incentive-based arms will be used to measure patient engagement with the study protocol and a dedicated research platform that involves ecological momentary assessment (EMA), in which participants report their real-time symptoms and daily activities in response to randomly timed prompts, will be used to help assess the rest and recovery process among pediatric and adult patients after concussion.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
ReCoUPS: Incentive-Based and Real-Time Symptom and Activity Reporting After Concussion
Actual Study Start Date :
Mar 3, 2019
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Feb 5, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Streak incentive

Subjects start with no money in an account, but they earn a fixed amount with each response. In this arm, each adult report is worth $3.17 so an adult subject can earn up to $200 if he/she responds to all surveys. If an adult completes at least 75% of the reports, he/she will receive an $100 bonus for a total maximum of $300. In this arm, each child report is worth 0.52 cents so a child subject can earn up to $33 if he/she responds to all surveys. If a child completes at least 75% of the reports, he/she will receive a $17 bonus for a total maximum of $50.

Behavioral: Streak incentive
Participants will receive prompts 3 times a day for 21 days prompting them to complete surveys. They will start with a $0 balance and will earn a fixed amount for each response.

Experimental: Loss-based incentive

Subjects start with the maximum possible compensation, but money is deducted for each missed response. Adult subjects will lose $4.76 for each missed survey. Child subjects will lose $0.79 for each missed survey.

Behavioral: Loss-based incentive
Participants will receive prompts 3 times a day for 21 days prompting them to complete surveys. They will start with the maximum balance and will lose a fixed amount for each response they do not complete.

Active Comparator: Flat-fee control status quo condition

Subjects will receive the maximum possible compensation at the end of the study regardless of response rate.

Behavioral: Flat-fee control status quo condition
Participants will receive prompts 3 times a day for 21 days prompting them to complete surveys. They will receive the maximum compensation at the end of the study.

Active Comparator: Flat-Fitbit control status quo condition

Subjects will be compensated by keeping the Fitbit at the end of the study regardless of response rate.

Behavioral: Flat-Fitbit control status quo condition
Participants will receive prompts 3 times a day for 21 days prompting them to complete surveys. They will keep the Fitbit at the end of the study.

Outcome Measures

Primary Outcome Measures

  1. Participant adherence to completing daily survey [21 days]

    This is a study where each participant is sent a short survey (PCSI instrument) three times each day for 21 days. The participant is instructed to reply to each survey within several minutes of receiving the prompt. We are interested in the extent to which participants will adhere to this instruction. Therefore, the outcome of interest is whether or not the participant replied to a given survey prompt. When we evaluate patient adherence in the data, we do this by calculating the % of survey prompts to which a given participant responded. In sum, the outcome is adherence to the survey.

Secondary Outcome Measures

  1. Time to recovery [1 to 21 days]

    Assess and quantify the concussion recovery process by monitoring symptoms and cognitive and physical activity on a daily basis.

  2. Correlation between symptoms and physical activity [1-21 days]

    Determine if there is a correlation each day between the daily symptom score from the PCSI (0-126) and the number of hours spent exercising (physical activity).

  3. Patient-reported activity vs. objective measures of activity [1-21 days]

    Compare the patient-reported hours spent exercising on a given day to the patient's daily step count collected through Fitbit on that same day.

  4. Test Way to Health platform [1-21 days]

    Test Way to Health as a platform for efficiently randomizing and monitoring patients

  5. Correlation between symptoms and cognitive activity [1-21 days]

    Determine if there is a correlation each day between the daily symptom score from the PCSI (0-126) and the number of hours participants spent doing homework, napping, and using screens combined (cognitive activity).

Eligibility Criteria

Criteria

Ages Eligible for Study:
13 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Males or females ages 13 to 64 years.

  • Presents with head injury concerning for concussion in line with criteria specified in the most recent Consensus Statement on Concussion in Sport, defined as head trauma with neurologic impairment, including, but not limited to somatic (eg, headache), cognitive (eg, feeling like in a fog) and/or emotional symptoms (eg, lability) symptoms.

  • Within approximately 5 days of injury.

  • Ownership of a smartphone to report symptoms and activities.

  • Speak English.

  • Informed consent or parental/guardian permission and child assent for those under 18 years of age.

Exclusion Criteria:
  • Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104
2 The University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • Children's Hospital of Philadelphia
  • University of Pennsylvania

Investigators

  • Principal Investigator: Douglas Wiebe, PhD, University of Pennsylvania
  • Principal Investigator: Daniel Corwin, MD, Children's Hospital of Philadelphia
  • Principal Investigator: Christina Master, MD, Children's Hospital of Philadelphia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT04499937
Other Study ID Numbers:
  • 16-013326
First Posted:
Aug 5, 2020
Last Update Posted:
Oct 25, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 25, 2021